‘Alarming Disparities’ in Cancer Trends and Shift to Women, Younger Adults Richard Mark Kirkner January 17, 2025 +++ ++++ +++

RISK MITIGATION ‘Noteworthy’ Shift in Cancer Burden to Women ‘Alarming Disparities’ in Cancer Trends and Shift to Women, Younger Adults Richard Mark Kirkner https://www.medscape.com/viewarticle/alarming-disparities-cancer-trends-and-shift-women-younger-2025a1000166?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572 January 17, 2025 Reduce Breast Cancer Risk With Plant-Based Diet? Growing Evidence Suggests Plant-Based Diets Reduce Cancer Risk Tara Haelle https://www.medscape.com/viewarticle/growing-evidence-suggests-plant-based-diets-reduce-cancer-2025a100011d?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572 January 16, 2025 Airborne Dioxins May Up Breast Cancer Risk Airborne Dioxin Pollution May Increase Breast Cancer Risk Miriam Davis, PhD | https://www.medscape.co.uk/viewarticle/airborne-dioxin-pollution-may-increase-breast-cancer-risk-2024a1000m56?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572&sso=true TREATMENT ADVANCES PARP Inhibitor Extends Survival in High-Risk Breast Cancer Olaparib Continues to Protect Patients From High-Risk Cancer Recurrences Neil Osterweil https://www.medscape.com/viewarticle/olaparib-continues-protect-patients-high-risk-cancer-2024a1000mzd?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572 CDK 4/6 Blocker Prolongs Survival in HER2+ Mets Breast Cancer CDK 4/6 Blocker Prolongs Survival in HER2+ Metastatic Breast Cancer M. Alexander Otto, PA, MMS https://www.medscape.com/viewarticle/cdk-4-6-blocker-prolongs-survival-her2-metastatic-breast-2025a10000fe?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572 January 09, 2025 New ADC for HR+, HER2- Breast Cancer FDA Approves New ADC for HR+, HER2- Breast Cancer Sharon Worcester, MA https://www.medscape.com/viewarticle/fda-approves-new-adc-hr-her2-breast-cancer-2025a100017n?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572 January 17, 2025 T-DXd Shows Strong Efficacy for HER2-Low Breast Cancer T-DXd Shows Consistent Benefit Across Endocrine-Resistant HR+/HER2-Low Breast Cancer Subgroups Christos Evangelou, MSc, PhD https://www.medscape.com/viewarticle/t-dxd-shows-consistent-benefit-across-endocrine-resistant-hr-2024a1000ojy?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572 December 19, 2024 LONG-TERM MANAGEMENT Oncs or PCPs to Lead Breast Cancer Survivorship Care? Oncologists More Often Provide Long-Term Care of Breast Cancer Survivors Than PCPs Edited by Katie Lennon https://www.medscape.com/viewarticle/oncologists-more-often-provide-long-term-care-breast-cancer-2024a1000n1x?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572 December 13, 2024 Immediate Surgery Improves Long-Term Survival in Older Patients Immediate Surgery Significantly Improves Long-Term Survival in Older Breast Cancer Patients, Meta-Analysis Shows Christos Evangelou, MSc, PhD https://www.medscape.com/viewarticle/immediate-surgery-significantly-improves-long-term-survival-2024a1000mz3?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572 December 12, 2024 Can Some Patients Safely Skip Postmastectomy Radiation? Can Some Patients Safely Skip Postmastectomy Radiation? M. Alexander Otto, PA, MMS https://www.medscape.com/viewarticle/can-some-patients-safely-skip-postmastectomy-radiation-2025a10000fw?ecd=mkm_ret_250126_mscpmrk_onc_breast_etid7184572&uac=148436CN&impID=7184572 January 09, 2025